InvestorsHub Logo
Followers 61
Posts 4040
Boards Moderated 0
Alias Born 01/12/2011

Re: criqsus post# 2710

Tuesday, 01/12/2021 10:39:22 AM

Tuesday, January 12, 2021 10:39:22 AM

Post# of 5667
Surely this is also a positive as well:

January 12, 2021 07:52 ET | Source: Ocugen
MALVERN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced it has determined to withdraw from stockholder consideration Item 2 set forth in its Definitive Proxy Statement filed with the Securities and Exchange Commission on October 30, 2020, with respect to an increase in the number of shares of common stock authorized for issuance under the Company’s Sixth Amended and Restated Certificate of Incorporation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News